Shengwang Liang

1.0k total citations
72 papers, 842 citations indexed

About

Shengwang Liang is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Shengwang Liang has authored 72 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 32 papers in Complementary and alternative medicine and 17 papers in Pharmacology. Recurrent topics in Shengwang Liang's work include Traditional Chinese Medicine Analysis (26 papers), Metabolomics and Mass Spectrometry Studies (16 papers) and Spectroscopy and Chemometric Analyses (12 papers). Shengwang Liang is often cited by papers focused on Traditional Chinese Medicine Analysis (26 papers), Metabolomics and Mass Spectrometry Studies (16 papers) and Spectroscopy and Chemometric Analyses (12 papers). Shengwang Liang collaborates with scholars based in China and United States. Shengwang Liang's co-authors include Shumei Wang, Minghua Xian, Mengjuan Gong, Huiting Lin, Bin Han, Qu Liu, Yali Liu, Yongxia Yang, Lan Luo and Chao Chen and has published in prestigious journals such as Molecules, Analytica Chimica Acta and Journal of Ethnopharmacology.

In The Last Decade

Shengwang Liang

71 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengwang Liang China 18 427 209 164 137 115 72 842
Yan‐Yan Chen China 19 535 1.3× 206 1.0× 106 0.6× 224 1.6× 57 0.5× 59 958
Kelvin Chan Australia 20 451 1.1× 272 1.3× 135 0.8× 118 0.9× 73 0.6× 54 1.1k
Defeng Li China 17 466 1.1× 283 1.4× 69 0.4× 212 1.5× 90 0.8× 45 872
Hui‐Kang Liu Taiwan 20 514 1.2× 205 1.0× 162 1.0× 113 0.8× 82 0.7× 64 1.2k
Guangyue Su China 20 454 1.1× 113 0.5× 87 0.5× 185 1.4× 85 0.7× 58 946
Feng Sui China 17 606 1.4× 183 0.9× 212 1.3× 253 1.8× 74 0.6× 45 1.3k
Xixiang Ying China 22 578 1.4× 353 1.7× 220 1.3× 132 1.0× 172 1.5× 85 1.3k

Countries citing papers authored by Shengwang Liang

Since Specialization
Citations

This map shows the geographic impact of Shengwang Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengwang Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengwang Liang more than expected).

Fields of papers citing papers by Shengwang Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengwang Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengwang Liang. The network helps show where Shengwang Liang may publish in the future.

Co-authorship network of co-authors of Shengwang Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Shengwang Liang. A scholar is included among the top collaborators of Shengwang Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengwang Liang. Shengwang Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liang, Shengwang, et al.. (2023). Extraction and structural profiling of polysaccharides from Rehmannia glutinosa and anti-inflammatory action via the NF-κB/IκBα pathway. Industrial Crops and Products. 208. 117874–117874. 7 indexed citations
3.
Shen, Lin, Huiting Lin, Tao Hu, et al.. (2022). Cyclo-(Phe-Tyr) as a novel cyclic dipeptide compound alleviates ischemic/reperfusion brain injury via JUNB/JNK/NF-κB and SOX5/PI3K/AKT pathways. Pharmacological Research. 180. 106230–106230. 19 indexed citations
4.
Liang, Shengwang, et al.. (2016). Adance Research of Digitalization in Quality Control of Chinese Medicine. 22(11). 229. 2 indexed citations
5.
Yang, Yongxia, Yaling Wang, Jingli Zhang, et al.. (2015). System responses to chronic cold stress probed via 1H NMR spectroscopy in plasma and urine matrices. Molecular BioSystems. 11(5). 1425–1433. 7 indexed citations
6.
Yang, Yongxia, Linlin Wang, Shumei Wang, et al.. (2014). An integrated metabonomic approach to studying metabolic profiles in rat models with insulin resistance induced by high fructose. Molecular BioSystems. 10(7). 1803–1811. 17 indexed citations
7.
Liang, Shengwang. (2013). Simultaneous Determination of Puerarin,3-Methoxy Puerarin,Mirificin and Daidzin in the Bioactive Fraction of Naodesheng Prescription by RP-HPLC/UV Method. Journal of Instrumental Analysis. 2 indexed citations
8.
Yang, Yongxia, Lijing Wang, Shumei Wang, et al.. (2013). Study of metabonomic profiles of human esophageal carcinoma by use of high-resolution magic-angle spinning 1H NMR spectroscopy and multivariate data analysis. Analytical and Bioanalytical Chemistry. 405(10). 3381–3389. 34 indexed citations
9.
Liang, Shengwang. (2012). Urinary Metabonomic Study of Kidney-yang Deficiency Syndrome Induced by Hydrocortisone. Zhongguo shiyan fangjixue zazhi. 4 indexed citations
10.
Liang, Shengwang. (2012). Study on effects of extract in Naomaitong Formula on cerebral ischemia-reperfusion model based on NMR metabolomics. Zhongcaoyao. 7 indexed citations
11.
Liang, Shengwang. (2012). In-vivo Study of Metabolism of Trifolirhizin in Rats. Traditional Chinese Drug Research and Clinical Pharmacology. 2 indexed citations
12.
Chen, Chao, Shuxian Li, Shumei Wang, & Shengwang Liang. (2012). Investigation into the anti-thrombosis effect and contents of total saponins and flavonoids in the bioactive fraction of Naodesheng prescription. Journal of Ethnopharmacology. 144(1). 208–212. 18 indexed citations
13.
Liang, Shengwang. (2011). Chemical constituents from frankincense. Zhongcaoyao. 3 indexed citations
14.
Liang, Shengwang. (2011). Study on chemical constituents from Sophora flavescens. 5 indexed citations
15.
Chen, Chao, Shuxian Li, Shumei Wang, & Shengwang Liang. (2011). A support vector machine based pharmacodynamic prediction model for searching active fraction and ingredients of herbal medicine: Naodesheng prescription as an example. Journal of Pharmaceutical and Biomedical Analysis. 56(2). 443–447. 17 indexed citations
16.
Li, Shuxian, Feng Wang, Xiaohui Deng, & Shengwang Liang. (2010). A new alkaloid from the stem ofSparganium stoloniferumBuch.-Ham. Journal of Asian Natural Products Research. 12(4). 331–333. 9 indexed citations
17.
Liang, Shengwang. (2007). The Quality Evaluation of the Different Collection Periods and Processing Technologies of Flos Lonicerae in Henan. Lishizhen Medicine and Materia Medica Research. 1 indexed citations
18.
Liang, Shengwang. (2006). Pharmacodynamic fingerprint of Flos Lonicerea by HPLC. Zhongcaoyao. 2 indexed citations
19.
Liang, Shengwang. (2004). The selecting of protective role of rhubarb’seffective parts in ischemic injury in rats. Zhongguo laonianxue zazhi. 1 indexed citations
20.
Liang, Shengwang, et al.. (1997). Determination of solasodine in Solanum nigrum by TLCS. 32(8). 494–495. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026